logo
Plus   Neg
Share
Email

EARNINGS SUMMARY: Details of Nektar Therapeutics Q2 Earnings Report

Below are the earnings highlights for Nektar Therapeutics (NKTR):

-Earnings: -$80.00 million in Q2 vs. -$110.29 million in the same period last year.
-EPS: -$0.45 in Q2 vs. -$0.63 in the same period last year.
-Analysts projected -$0.68 per share
-Revenue: $48.85 million in Q2 vs. $23.32 million in the same period last year.

For comments and feedback contact: editorial@rttnews.com

RELATED NEWS
Follow RTT